Australian shares fell as banks weighed on sentiment and biotech leader CSL plunged 16% after cutting its full-year 2026 outlook. The company also flagged a $5 billion impairment, dragging the healthcare index 6.5% to an over eight-year low. Broader risk appetite was further dented by rising US-Iran tensions influencing global markets.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
